Potential drugs may ease pain but not affect mood

01/15/2014 | Wired.co.uk (U.K.)

Biochemists at Scripps Research Institute are studying two compounds that target the kappa opioid receptor to help develop therapies for pain and addiction without affecting mood. The goal is to activate the receptor without using beta arrestin, which researchers said was linked to the process that can cause mood problems, such as depression, in people taking the pain drugs.

View Full Article in:

Wired.co.uk (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Chief Medical Officer
Meritus
Tempe, AZ
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX